Evidence map›Paper›PMID 41971103›Full record

ArticleIJID regions2026

Molecular epidemiologic characterization of methicillin-resistant

Takayuki Satoh, Meiji Soe Aung, Satoshi Fujii, Nobumichi Kobayashi, Koh Nakayama

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Takayuki SatohDepartment of Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
Meiji Soe AungDivision of Hygiene, Department of Social Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Satoshi FujiiDivision of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan.
Nobumichi KobayashiDivision of Hygiene, Department of Social Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
Koh NakayamaDepartment of Pharmacology, Asahikawa Medical University, Asahikawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methicillin-resistant Methods: Clinical isolates of MRSA were collected from Asahikawa Medical University Hospital, located in Hokkaido, a northernmost region in Japan, for a 14-month period. They were analyzed for their genotypes, virulence factors, and antimicrobial resistance profiles. Results: Among a total of 235 MRSA isolates collected during the study period, the dominant SCC Conclusions: Clonal structure of MRSA in the northernmost region of Japan was revealed, suggesting the spread of emerging clones (e.g. ST22-MRSA-PT) to the remote area.

Indexed as

JapanMRSANorthernmost regionSCCmec-IVaST22-PT

Identifiers

PMID41971103
PMCPMC13068588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.